WST · NYSE
West Pharmaceutical Services, Inc.
$391.09 -3.14 (-0.80%)
Company overview
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates through two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems, as well as syringe and cartridge components, including custom solutions for injectable drug applications and administration systems that enhance safe drug delivery through advanced reconstitution, mixing, and transfer technologies. It also provides films, coatings, washing, vision inspection, and sterilization processes and services to improve packaging component quality.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Exchange
- NYSE
- Market cap
- $27.5B
- Employees
- 10,600
- Headquarters
- Exton, PA
- Website
- westpharma.com
- CEO
- Eric Green
- Listed
- March 17, 1980
- P/E
- 52.01
- Dividend yield
- 0.26%
Company financials
- Revenue
- $3.2B
- Gross profit
- $1.2B
- Operating income
- $666M
- EBITDA
- $799M
- Net income
- $543M
- EPS
- $7.52
- Total assets
- $4.1B
- Total debt
- $316M
- Gross margin
- 36.24%
- Net margin
- 16.85%
- Earnings yield
- 1.92%
Showing FY 2025
WST
1D
NYSE
O391.66H394.18L390.03C390.89-3.14 (-0.80%)Vol168.57K